Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety and efficacy of Dotinurad in hyperuricemia
NCT03006445Phase 3Completed
- Sponsor
- Fuji Yakuhin
- Start
- Dec 2016
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dotinurad in hyperuricemia, gout, sponsored by Fuji Yakuhin. Started Dec 2016; status: completed.
02
Drugs
dotinurad
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on NCT03006445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03006445.